title: Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moieties.
abstract: A series of benzylidenemalononitrile derivatives previously synthesized by condensing aromatic aldehydes with malononitrile derivatives are known as tyrphostins. In this study, 32 tyrphostins were synthesized, 19 of which are novel compounds. Both hydroxylated derivatives and compounds containing heteroaromatic moieties were prepared. We have confirmed and extended the observation that the tyrphostins displayed an enhancement in their ability to inhibit the epidermal growth factor (EGF) receptor tyrosine kinase domain as the number of hydroxyl groups on the aromatic portion was increased. IC50 values of 1-5 microM were readily achieved. Some inhibitory activity was seen with the heteroaromatic structures, with two compounds exhibiting IC50 values of 56 and 77 microM. However, these derivatives were poor inhibitors of the EGF receptor tyrosine kinase activity as compared to the hydroxylated derivatives. The ability of the 32 tyrphostins synthesized in the present study to inhibit proliferation of a human breast adenocarcinoma cell line (MCF-7) was determined using [3H]thymidine incorporation as a measure of DNA synthesis. Some of the compounds containing pyridine, imidazole or thiophene portions displayed antiproliferative activity comparable to that of tyrphostins prepared from 3,4,5-trihydroxybenzaldehyde. The lack of inhibitory effect of these heteroaromatic compounds on the EGF receptor tyrosine kinase activity suggests that their antiproliferative activity is not related to inhibition of EGF receptor function. As the growth of the MCF-7 cell line is governed by other factors, such as the insulin-like growth factors (IGFs) and oestradiol, it is also still to be established whether the antiproliferative activity of the hydroxylated tyrphostins is directly related to inhibition of the EGF receptor tyrosine kinase activity.
authors.affiliation: Cancer Research Campaign Department of Medical Oncology, CRC Beatson Laboratories, University of Glasgow, Bearsden, UK.
authors.forename: V G
authors.initials: VG
authors.lastname: Brunton
authors.forename: M J
authors.initials: MJ
authors.lastname: Lear
authors.forename: D J
authors.initials: DJ
authors.lastname: Robins
authors.forename: S
authors.initials: S
authors.lastname: Williamson
authors.forename: P
authors.initials: P
authors.lastname: Workman
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002396:Catechols / Q000138:chemical synthesis* / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D009570:Nitriles / Q000138:chemical synthesis* / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D020032:Tyrphostins
chemical_list: D000970:Antineoplastic Agents; D002396:Catechols; D009570:Nitriles; D020032:Tyrphostins; C060152:tyrphostin 47; D066246:ErbB Receptors